myStoria Raises $1.625 Million in Seed Funding

myStoria, a digital health platform developed with input from fertility doctors and designed by patients, has successfully raised $1.625 million in a seed funding round. The round was led by Graphite Ventures, with additional investments from Conexus Venture Capital, Adrenaline Fund, and Phoenix Fire Fund. Founded by Jessica Chalk and Holly Tiessen, myStoria aims to assist patients in navigating the complexities of reproductive care by providing tools to track symptoms, manage diagnoses, and receive advice.

Company Vision and Platform

myStoria focuses on helping patients manage their reproductive health across often fragmented healthcare systems. The platform initially targeted fertility and IVF, which are known for long diagnostic delays and high rates of dismissal. With the new funding, myStoria plans to broaden its services to cover conditions such as PCOS, endometriosis, and perimenopause. The core of the platform is the proprietary "Context Engine," which aggregates and structures comprehensive patient health data, making it accessible and actionable through AI-powered tools.

Strategic Use of Funds

The newly acquired funds will be allocated to several key areas:

  • Development of the Context Engine: myStoria plans to enhance its data aggregation capabilities and expand its medical knowledge base.
  • Expansion of Care Pathways: The company will introduce condition-specific support across the reproductive health lifecycle.
  • Scaling Consumer Offerings: myStoria aims to broaden access to its platform by launching mobile apps on iOS and Android, utilizing a freemium model.

Future Directions

While myStoria is currently focused on reproductive health, the company has long-term plans to extend its platform to manage other complex health conditions, such as cancer, heart disease, and autoimmune disorders. By organizing and retaining longitudinal health data, the platform positions itself as a pivotal tool for patient-managed care.

Leadership Insights

Jessica Chalk, the founder of myStoria, emphasized the importance of providing a comprehensive support system for patients: "Reproductive health has the highest dismissal rates and the longest diagnostic delays, making our work crucial for improving patient experiences." Holly Tiessen, CRO and co-founder, also plays a significant role in guiding the company's strategic direction.

The funding marks a significant step for myStoria as it seeks to expand its reach and impact in the healthcare industry, empowering patients to take control of their reproductive health journey.